Altered Gene Expression Pattern in Peripheral Blood Mononuclear Cells in Patients with Acute Myocardial Infarction

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Kiliszek, Marek ^a   Burzynska, Beata ^b   Michalak, Marcin ^a   Gora, Monika ^b   Winkler, Aleksandra ^a   Maciejak, Agata ^b   Leszczynska, Agata ^b   Gajda, Ewa ^a   Kochanowski, Janusz ^a   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

ACUTE HEART INFARCTION; ADULT; AQP9 GENE; ARTICLE; ASGR2 GENE; CELL FUNCTION; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CR1 GENE; CYP1B1 GENE; DNA MICROARRAY; DYSF GENE; EGR1 GENE; EGR2 GENE; FAM20A GENE; FCGR1A GENE; FEMALE; FMN1 GENE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; HBEGF GENE; HP GENE; HUMAN; HUMAN CELL; KLRC2 GENE; KLRC4 GENE; LEUKOCYTE; MALE; MICROARRAY ANALYSIS; MYBL1 GENE; PPARG GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; RNASE1 GENE; RNASE2 GENE; SIGNAL TRANSDUCTION; SOCS3 GENE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ST14 GENE; STAB1 GENE; TCN2 GENE; TMEM176A GENE; VSIG4 GENE;

AGED; CORONARY ARTERY DISEASE; DENTAL ENAMEL PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84869859093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050054     Document Type: Article

References (38)

1. Barron HV, Harr SD, Radford MJ, Wang Y, Krumholz HM, (2001) The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol 38: 1654-1661.
2. Mueller C, Neumann FJ, Perruchoud AP, Buettner HJ, (2003) White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation. Heart 89: 389-392.
3. Ndrepepa G, Braun S, Iijima R, Keta D, Byrne RA, et al. (2009) Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention. Clin Sci (Lond) 116: 651-658.
4. Libby P, Ridker PM, Hansson GK, (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 19 473: 317-325.
5. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, et al. (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. European Heart Journal 29: 2909-2945.
6. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Research 29: e45.
7. Pfaffl MW, Horgan GW, Dempfle L, (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Research 30: e36.
8. Holley CL, Topkara VK, (2011) An Introduction to Small Non-coding RNAs: miRNA and snoRNA. Cardiovasc Drugs Ther 25: 151-159.
9. Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A, (2011) Suppressors of Cytokine Signaling (SOCS) Proteins and JAK/STAT Pathways: Regulation of T-Cell Inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol 31: 980-985.
10. Gupta GK, Dhar K, Del Core MG, Hunter WJ 3rd, Hatzoudis GI, et al (2011) Suppressor of cytokine signaling-3 and intimal hyperplasia in porcine coronary arteries following coronary intervention. Exp Mol Pathol 91: 346-52.
11. Oba T, Yasukawa H, Hoshijima M, Sasaki K, Futamata N, et al. (2012) Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction. J Am Coll Cardiol 59: 838-852.
12. Nalbant D, Youn H, Nalbant SI, Sharma S, Cobos E, et al. (2005) FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genomics 27: 6-11.
13. Darragh MR, Bhatt AS, Craik CS, (2008) MT-SP1 proteolysis and regulation of cell-microenvironment interactions. Front Biosci 13: 528-539.
14. Seitz I, Hess S, Schulz H, Eckl R, Busch G, et al. (2007) Membrane-type serine protease-1/matriptase induces interleukin-6 and-8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis. Arterioscler Thromb Vasc Biol 27: 769-775.
15. Weigel PH, (1994) Galactosyl and N-acetylgalactosaminyl homeostasis: a function for mammalian asialoglycoprotein receptors. Bioessays 16: 519-524.
16. Sørensen AL, Rumjantseva V, Nayeb-Hashemi S, Clausen H, Hartwig JH, et al. (2009) Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes. Blood 114: 1645-1654.
17. Magni F, Sarto C, Ticozzi D, Soldi M, Bosso N, et al. (2006) Proteomic knowledge of human aquaporins. Proteomics 6: 5637-5649.
18. Carbrey JM, Gorelick-Feldman DA, Kozono D, Praetorius J, Nielsen S, et al. (2003) Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver. Proc Natl Acad Sci USA 100: 2945-2950.
19. Rojek AM, Skowronski MT, Füchtbauer EM, Füchtbauer AC, Fenton RA, et al. (2007) Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc Natl Acad Sci U S A 104: 3609-3614.
20. Khachigian LM, (2006) Early Growth Response-1 in Cardiovascular Pathobiology. Circ Res 98: 186-191.
21. Khachigian LM, Lindner V, Williams AJ, Collins T, (1996) Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science 271: 1427-1431.
22. Harja E, Bucciarelli LG, Lu Y, Stern DM, Zou YS, et al. (2004) Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ Res 94: 333-339.
23. Asnani S, Theuma P, Fonseca VA, (2003) PPARgamma agonists and vascular risk factors: potential effects on cardiovascular disease. Metab Syndr Relat Disord 1: 23-32.
24. Zhang L, Chawla A, (2004) Role of PPARG in macrophage biology and atherosclerosis. Trends Endocrinol Metab 15: 500-505.
25. Vanderlaan PA, Reardon CA, (2005) Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 46: 829-838.
26. Millonig G, Malcom G, Wick G, (2002) Early inflammatory-immunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study. Atherosclerosis 160: 441-448.
27. Rosenberg HF, Tenen DG, Ackerman SJ, (1989) Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc Natl Acad Sci U S A 86: 4460-4464.
28. van der Poel CE, Spaapen RM, van de Winkel JG, Leusen JH, (2011) Functional Characteristics of the High Affinity IgG Receptor, FcgammaRI. The Journal of Immunology 186: 2699-2704.
29. Ohta Y, Stossel TP, Hartwig JH, (1991) Ligand-sensitive binding of actin-binding protein to immunoglobulin G Fc Receptor I (FcGRI). Cell Press 67: 275-282.
30. Jandeleit-Dahm KAM, Calkin A, Tikellis C, Thomas M, (2009) Direct antiatherosclerotic effects of PPAR agonists. Curr Opin Lipidol 20: 24-29.
31. Kaminski KA, Kozuch M, Bonda T, Wojtkowska I, Kozieradzka A, et al. (2009) Coronary sinus concentrations of interleukin 6 and its soluble receptors are affected by reperfusion and may portend complications in patients with myocardial infarction. Atherosclerosis 206: 581-587.
32. Tan J, Hua Q, Li J, Fan Z, (2009) Prognostic value of interleukin-6 during a 3-year follow-up in patients with acute ST-segment elevation myocardial infarction. Heart Vessels 24: 329-334.
33. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R, (1999) Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol 19: 2364-2367.
34. Yoshimura A, Naka T, Kubo M, (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454-465.
35. Ait-Oufella H, Taleb S, Mallat Z, Tedgui A, (2011) Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol 31: 969-979.
36. Potteaux S, Esposito B, van Oostrom O, Brun V, Ardouin P, et al. (2004) Leukocyte-derived interleukin 10 is required for protection against atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 24: 1474-1478.
37. Cavusoglu E, Marmur JD, Hojjati MR, Chopra V, Butala M, et al. (2011) Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome. Am J Med 124: 724-730.
38. Calkin AC, Tontonoz P, (2010) Liver × Receptor Signaling Pathways and Atherosclerosis. Arterioscler Thromb Vasc Biol 30: 1513-1518.